Marker Therapeutics, Inc.

Tagged: breast cancer symposium

TapImmune to Present New Data at San Antonio Breast Cancer Symposium on December 10, 2015

…TapImmune, Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today announced its Chairman and CEO, Dr. Glynn Wilson, will be presenting new data at the 2015 San Antonio Breast Cancer Symposium, which will be held in San Antonio, Texas on December 8 – 12, 2015.

Read More